Announcement
Collapse
No announcement yet.
Treatments
Collapse
There are no conversations in this channel.
Please log in to your account to view your subscribed posts.
Topics | Statistics | Last Post | ||
---|---|---|---|---|
Sci Rep . Acute estradiol and progesterone therapy in hospitalized adults to reduce COVID-19 severity: a randomized control trial
by tetano
Started by tetano, October 1, 2024, 03:23 AM
|
0 responses
17 views
0 likes
|
Last Post
by tetano
October 1, 2024, 03:23 AM
|
||
Front Immunol . The role of convalescent plasma and hyperimmune immunoglobulins in the COVID-19 pandemic, including implications for future preparedness
by tetano
Started by tetano, September 27, 2024, 03:21 AM
|
0 responses
33 views
0 likes
|
Last Post
by tetano
September 27, 2024, 03:21 AM
|
||
Started by tetano, September 27, 2024, 02:45 AM
|
1 response
20 views
0 likes
|
Last Post
by tetano
September 27, 2024, 02:46 AM
|
||
Clin Infect Dis . Effects of Losartan on Patients Hospitalized for Acute COVID-19: A Randomized Controlled Trial
by tetano
Started by tetano, September 27, 2024, 02:35 AM
|
0 responses
18 views
0 likes
|
Last Post
by tetano
September 27, 2024, 02:35 AM
|
||
Expert Rev Clin Pharmacol . Population pharmacokinetics of nirmatrelvir/ritonavir in critically ill Chinese COVID-19 patients and recommendations for medication use: a two-center retrospective study
by tetano
Started by tetano, September 27, 2024, 02:35 AM
|
0 responses
16 views
0 likes
|
Last Post
by tetano
September 27, 2024, 02:35 AM
|
||
PLoS One . The heat shock protein 90 inhibitor RGRN-305 attenuates SARS-CoV-2 spike protein-induced inflammation in vitro but lacks effectiveness as COVID-19 treatment in mice
by tetano
Started by tetano, September 27, 2024, 02:33 AM
|
0 responses
18 views
0 likes
|
Last Post
by tetano
September 27, 2024, 02:33 AM
|
||
Started by tetano, September 27, 2024, 02:28 AM
|
0 responses
7 views
0 likes
|
Last Post
by tetano
September 27, 2024, 02:28 AM
|
||
Started by tetano, September 27, 2024, 02:28 AM
|
0 responses
11 views
0 likes
|
Last Post
by tetano
September 27, 2024, 02:28 AM
|
||
Started by tetano, September 27, 2024, 02:27 AM
|
0 responses
9 views
0 likes
|
Last Post
by tetano
September 27, 2024, 02:27 AM
|
||
J Infect Chemother . Tocilizumab in combination with standard of care in patients with severe COVID-19 pneumonia: efficacy and safety from a phase 3 clinical trial in Japan
by tetano
Started by tetano, September 27, 2024, 02:26 AM
|
0 responses
12 views
0 likes
|
Last Post
by tetano
September 27, 2024, 02:26 AM
|
No topics found.
-
Page of 0
-
Filter